Insider Transactions in Q1 2023 at Avantor, Inc. (AVTR)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 31
2023
|
Justin Miller EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
7,942
-7.44%
|
$182,666
$23.9 P/Share
|
|
Jan 31
2023
|
Justin Miller EVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
26,818
+20.07%
|
-
|
|
Jan 31
2023
|
Gerard Brophy EVP, Biopharma Production |
SELL
Payment of exercise price or tax liability
|
Direct |
15,221
-11.8%
|
$350,083
$23.9 P/Share
|
|
Jan 31
2023
|
Gerard Brophy EVP, Biopharma Production |
BUY
Grant, award, or other acquisition
|
Direct |
38,737
+23.1%
|
-
|
|
Jan 31
2023
|
Michael Stubblefield President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
91,140
-7.0%
|
$2,096,220
$23.9 P/Share
|
|
Jan 31
2023
|
Michael Stubblefield President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
223,482
+14.66%
|
-
|
|
Jan 31
2023
|
Christophe Couturier EVP, AMEA |
SELL
Payment of exercise price or tax liability
|
Direct |
7,658
-6.09%
|
$176,134
$23.9 P/Share
|
|
Jan 31
2023
|
Christophe Couturier EVP, AMEA |
BUY
Grant, award, or other acquisition
|
Direct |
26,818
+17.57%
|
-
|
|
Jan 02
2023
|
Frederic Vanderhaegen EVP, Americas and Europe |
SELL
Payment of exercise price or tax liability
|
Direct |
1,017
-0.8%
|
$21,357
$21.09 P/Share
|
|
Jan 02
2023
|
Thomas A Szlosek EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,313
-7.06%
|
$174,573
$21.09 P/Share
|
|
Jan 02
2023
|
Gerard Brophy EVP, Biopharma Production |
SELL
Payment of exercise price or tax liability
|
Direct |
6,727
-6.94%
|
$141,267
$21.09 P/Share
|